Decision

Early access to medicines scheme (EAMS) scientific opinion: Nivolumab to treat a type of cancer of the lymph system

This publication was withdrawn on

The positive scientific opinion for nivolumab to treat a type of cancer of the lymph system has lapsed because it has been granted an EC commission decision for this indication.

EAMS scientific opinion given to Nivolumab to treat a type of cancer of the lymph system, including the public assessment report.